Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chloë Goossens
Observed names:
C Goossens,
C. Goosens
Institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen,
Comprehensive Cancer Center Erlangen
Observed institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen,
Comprehensive Cancer Center Erlangen
ORCID:
0009-0009-2809-8082
Observed ORCID:
0009-0009-2809-8082
OpenAlex ID:
A5133427735
PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer—Results from the prospective PRAEGNANT registry
2026
·
Manuel Hörner
, Andreas Hartkopf
, et al.
·
npj Breast Cancer
·
5
PDF
Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial
2026
·
Manuel Hörner
, Lara M. Tretschock
, et al.
·
Breast Cancer Research and Treatment
·
2
PDF
Chemotherapy‐Induced Nausea and Vomiting in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy With Fluorouracil, Epirubicin, Cyclophosphamide Followed by Docetaxel Versus an Anthracycline‐Free Regimen With Docetaxel, Cyclophosphamide—Results From a Randomized Clinical Trial
2026
·
Manuel Hörner
, Henning Schäffler
, et al.
·
International Journal of Cancer
·
1
Häusliche Blutwertüberwachung unter oraler Brustkrebstherapie: Entwicklung und Machbarkeit eines Digital Home Health Care Centers
2026
·
H Hübner
, S Altmannshofer
, et al.
·
Geburtshilfe und Frauenheilkunde
Impact of Pre-Chemotherapy Food Intake on Chemotherapy-Induced Nausea and Vomiting in Patients with Early Breast Cancer: A Subanalysis of the randomized SUCCESS-C Trial
2026
·
H Schäffler
, M Hörner
, et al.
·
Senologie - Zeitschrift für Mammadiagnostik und -therapie
Die BayPass App – digitale Brustkrebsprävention und Risikoevaluation
2024
·
S. Altmannshofer
, S. Lehle
, et al.
·
Geburtshilfe und Frauenheilkunde
Show more works
View as search
Works count:
6
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type